Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IFNα and 5-Aza-2’-deoxycytidine combined with a dendritic-cell targeting DNA vaccine alter tumor immune cell infiltration in the B16F10 melanoma model
James T. Gordy, Avinaash K. Sandhu, Kaitlyn Fessler, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 11

Showing 11 citing articles:

Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target
Feyza Gül Özbay Kurt, Samantha Lasser, Ihor Arkhypov, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 13
Open Access | Times Cited: 54
Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond
Yang Zhao, Junfeng Du, Xiaofei Shen
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 38
Components, Formulations, Deliveries, and Combinations of Tumor Vaccines
Tengfei Liu, Wenyan Yao, Wenyu Sun, et al.
ACS Nano (2024) Vol. 18, Iss. 29, pp. 18801-18833
Closed Access | Times Cited: 5
Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy
Shuyan He, Lu Zheng, Chunjian Qi
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
The epigenetic hallmarks of immune cells in cancer
Ji Yu, Chu Xiao, Tao Fan, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Outsmarting trogocytosis to boost CAR NK/T cell therapy
Faezeh Ramezani, Ahmad Reza Panahi Meymandi, Behnia Akbari, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 13
Tumor Microenvironment Heterogeneity, Potential Therapeutic Avenues, and Emerging Therapies
Xintong Peng, Jingfan Zheng, Tianzi Liu, et al.
Current Cancer Drug Targets (2023) Vol. 24, Iss. 3, pp. 288-307
Closed Access | Times Cited: 3
Combination of a MIP3α-antigen fusion therapeutic DNA vaccine with treatments of IFNα and 5-Aza-2’Deoxycytidine enhances activated effector CD8+ T cells expressing CD11c in the B16F10 melanoma model
Kaitlyn Fessler, Jiaqi Zhang, Avinaash K. Sandhu, et al.
Research Square (Research Square) (2024)
Open Access
MIP3α-RelMtb intranasal DNA vaccination induces reactive T-cell infiltration into the lungs in mice and macaques
James T. Gordy, Jean J. Zheng, Amanda Maxwell, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Brief Communication: Combination of an MIP3α-Antigen Fusion Therapeutic DNA Vaccine With Treatments of IFNα and 5-Aza-2′Deoxycytidine Enhances Activated Effector CD8+ T Cells Expressing CD11c in the B16F10 Melanoma Model
Kaitlyn Fessler, Jiaqi Zhang, Avinaash K. Sandhu, et al.
Journal of Immunotherapy (2024)
Closed Access
Combination of a MIP3α-antigen fusion therapeutic DNA vaccine with treatments of IFNα and 5-Aza-2’Deoxycytidine enhances activated effector CD8+ T cells expressing CD11c in the B16F10 melanoma model
Kaitlyn Fessler, James T. Gordy, Avinaash K. Sandhu, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top